FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval
/PRNewswire/ -- Today, the U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer's Disease, to...
Source: prnewswire.com